RPS Diagnostics

Most Cost-Effective Antibiotic Stewardship Solution: FebriDx

RPS Diagnostics develops, manufactures, and markets cost-effective point-of-care tests for infectious and inflammatory disease. The company’s innovative and patented FebriDx® test is a rapid, disposable, in-office test that uses a fingerstick blood sample to help identify a clinically significant systemic host immune response and differentiate bacterial from viral causes for acute respiratory infection. With a 97-99% negative predictive value, FebriDx delivers results in 10 minutes and can be used to help triage infectious patients during the initial encounter, providing clinicians with actionable information that can be used to limit unnecessary antibiotics and support antibiotic stewardship. For more information, visit RPSdetectors.com.